PuSH - Publication Server of Helmholtz Zentrum München

Journal browsing

93 Records found.
Zum Exportieren der Ergebnisse bitte einloggen.
Lay all publications on this page into basket
1.
Aslam. A.A.* et al.: Diabetes and obesity in down syndrome across the lifespan: A retrospective cohort study using U.K. electronic health records. Diabetes Care, DOI: 10.2337/dc22-0482:dc220482 (2022)
2.
Auzanneau, M.* et al.: Frequency of ketoacidosis at diagnosis of pediatric type 1 diabetes associated with socioeconomic deprivation and Uubanization: Results from the German Multicenter DPV Registry. Diabetes Care 45, 1807-1813 (2022)
3.
Heianza, Y.* et al.: Changes in circulating miR-375-3p and improvements in visceral and hepatic fat contents in response to lifestyle interventions: The CENTRAL trial. Diabetes Care 45, 1911-1913 (2022)
4.
Jacobsen, L.M.* et al.: Heterogeneity of DKA incidence and age-specific clinical characteristics in children diagnosed with type 1 diabetes in the TEDDY Study. Diabetes Care 45, 624-633 (2022)
5.
Karl, F. ; Winkler, C. ; Ziegler, A.-G. ; Laxy, M. & Achenbach, P.: Costs of public health screening of children for presymptomatic type 1 diabetes in Bavaria, Germany. Diabetes Care 45, 837-844 (2022)
6.
Krischer, J.P.* et al.: Predictors of the initiation of islet autoimmunity and progression to multiple autoantibodies and clinical diabetes: The TEDDY study. Diabetes Care 45, 2271-2281 (2022)
7.
Küpers, L.K.* et al.: Maternal dietary glycemic index and glycemic load in pregnancy and offspring cord blood DNA methylation. Diabetes Care 45, 1822-1832 (2022)
8.
Rossing, P.* et al.: Finerenone in patients with chronic kidney disease and type 2 diabetes by sodium-glucose cotransporter 2 inhibitor treatment: The FIDELITY analysis. Diabetes Care, DOI: 10.2337/dc22-0294 (2022)
9.
Schlögl, H. & Stumvoll, M.*: The brains behind SGLT2 inhibition. Diabetes Care 45, 273-275 (2022)
10.
Tobi, E.W.* et al.: Maternal glycemic dysregulation during pregnancy and neonatal blood DNA methylation: Meta-analyses of epigenome-wide association studies. Diabetes Care 45, 614-623 (2022)
11.
Vehik, K.* et al.: Rising hemoglobin A1c in the nondiabetic range predicts progression of type 1 diabetes as well as oral glucose tolerance tests. Diabetes Care 45, 2342-2349 (2022)
12.
Ahuja, V.* et al.: Accuracy of 1-hour plasma glucose during the oral glucose tolerance test in diagnosis of type 2 diabetes in adults: A meta-analysis. Diabetes Care 44, 1062-1069 (2021)
13.
Anand, V.* et al.: Islet autoimmunity and HLA markers of presymptomatic and clinical type 1 diabetes: Joint analyses of prospective cohort studies in Finland, Germany, Sweden, and the U.S. Diabetes Care 44, 2269-2276 (2021)
14.
Bizzotto, R.* et al.: Processes underlying glycemic deterioration in type 2 diabetes: An IMI DIRECT Study. Diabetes Care 44, 511-518 (2021)
15.
Blonde, L.* et al.: Durable effects of iGlarLixi up to 52 weeks in type 2 diabetes: The LixiLan-G Extension Study. Diabetes Care 44, 774-780 (2021)
16.
Bonifacio, E. et al.: An age-related exponential decline in the risk of multiple islet autoantibody seroconversion during childhood. Diabetes Care 44, 2260-2268 (2021)
17.
Canouil, M.* et al.: Epigenome-wide association study reveals methylation loci associated with offspring gestational diabetes mellitus exposure and maternal methylome. Diabetes Care 44, 1992-1999 (2021)
18.
Kullmann, S. et al.: Empagliflozin improves insulin sensitivity of the hypothalamus in humans with prediabetes: A randomized, double-blind, placebo-controlled, phase 2 trial. Diabetes Care 45, 398-406 (2021)
19.
Neuwahl, S.J.* et al.: Patient health utility equations for a type 2 diabetes model. Diabetes Care 44, 381-389 (2021)
20.
Ng, K.* et al.: Islet autoantibody type-specific titer thresholds improve stratification of risk of progression to type 1 diabetes in children. Diabetes Care 45, 160-168 (2021)